A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapy

Recent Results Cancer Res. 1993;127:23-33. doi: 10.1007/978-3-642-84745-5_4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Models, Biological
  • Neoplasm Recurrence, Local
  • Survival Rate
  • Tamoxifen / therapeutic use*

Substances

  • Tamoxifen